High concentration local anesthetic formulations

Details for Australian Patent Application No. 2012202327 (hide)

Owner Arcion Therapeutics, Inc.

Inventors Campbell, James N.; Michaelis, Arthur F.

Agent FB Rice

Pub. Number AU-A-2012202327

Parent 2008289109

Filing date 19 April 2012

Wipo publication date 10 May 2012

International Classifications

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

3 May 2012 Complete Application Filed

10 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202327

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202328-New Association Between 4-{3-[cis-Hexahydrocyclopenta[c]pyrrol2(1H)-yl]-propoxy}Benzamide and an Acetylcholinesterase inhibitor, and Pharmaceutical Compositions Containing It

2012202326-Treatment of length dependent neuropathy